Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $169.3800 (-2.59%) ($169.3800 - $175.5500) on Thu. Feb. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.08% (three month average) | RSI | 54 | Latest Price | $169.3800(-2.59%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(34%) VYM(29%) VFMO(28%) XBI(27%) IBB(26%) | Factors Impacting UTHR price | UTHR will decline at least -1.04% in a week (0% probabilities). VIXM(-22%) VXX(-16%) UUP(-12%) TLT(-3%) BND(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.04% (StdDev 2.08%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $169.73 | 5 Day Moving Average | $172.95(-2.06%) | 10 Day Moving Average | $171.44(-1.2%) | 20 Day Moving Average | $169.73(-0.21%) | To recent high | -3.2% | To recent low | 30.5% | Market Cap | $7.513b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |